Application 206488
- Type
- NDA
- Sponsor
- SAREPTA THERAPS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EXONDYS 51 | ETEPLIRSEN | SOLUTION;INTRAVENOUS | 100MG/2ML (50MG/ML) | Yes | Yes |
| 002 | EXONDYS 51 | ETEPLIRSEN | SOLUTION;INTRAVENOUS | 500MG/10ML (50MG/ML) | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N206488-001 | EXONDYS 51 | ETEPLIRSEN | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | |
| N206488-002 | EXONDYS 51 | ETEPLIRSEN | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N206488-001 | RE48468 | 2028-10-27 | U-2097 | 2021-04-12 | |
| N206488-001 | RE47769 | 2029-02-02 | Drug product | 2019-12-18 | |
| N206488-001 | 10337003 | 2034-03-14 | U-1918 | 2019-09-10 | |
| N206488-001 | 10364431 | 2034-03-14 | U-1918 | 2019-08-28 | |
| N206488-001 | 10364431 | 2034-03-14 | U-1919 | 2019-08-28 | |
| N206488-001 | 9506058 | 2034-03-14 | U-1918 | 2016-12-01 | |
| N206488-001 | 9506058 | 2034-03-14 | U-1919 | 2016-12-01 | |
| N206488-002 | RE48468 | 2028-10-27 | U-2097 | 2021-04-12 | |
| N206488-002 | RE47769 | 2029-02-02 | Drug product | 2019-12-18 | |
| N206488-002 | 10337003 | 2034-03-14 | U-1918 | 2019-09-10 | |
| N206488-002 | 10364431 | 2034-03-14 | U-1918 | 2019-08-28 | |
| N206488-002 | 10364431 | 2034-03-14 | U-1919 | 2019-08-28 | |
| N206488-002 | 9506058 | 2034-03-14 | U-1918 | 2016-12-01 | |
| N206488-002 | 9506058 | 2034-03-14 | U-1919 | 2016-12-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 05:41 UTC | 2022-04 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N206488-001 | EXONDYS 51 | 100MG/2ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | N206488-002 | EXONDYS 51 | 500MG/10ML (50MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2016-09-19 | 3bdfa0b2c4d7… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N206488-001 | RE48468 | 2028-10-27 | U-2097 | 2021-04-12 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N206488-001 | RE47769 | 2029-02-02 | Drug product | 2019-12-18 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N206488-001 | 10337003 | 2034-03-14 | U-1918 | 2019-09-10 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N206488-001 | 10364431 | 2034-03-14 | U-1919 | 2019-08-28 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N206488-001 | 10364431 | 2034-03-14 | U-1918 | 2019-08-28 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N206488-001 | 9506058 | 2034-03-14 | U-1918 | 2016-12-01 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N206488-001 | 9506058 | 2034-03-14 | U-1919 | 2016-12-01 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N206488-002 | RE48468 | 2028-10-27 | U-2097 | 2021-04-12 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N206488-002 | RE47769 | 2029-02-02 | Drug product | 2019-12-18 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N206488-002 | 10337003 | 2034-03-14 | U-1918 | 2019-09-10 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N206488-002 | 10364431 | 2034-03-14 | U-1919 | 2019-08-28 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N206488-002 | 10364431 | 2034-03-14 | U-1918 | 2019-08-28 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N206488-002 | 9506058 | 2034-03-14 | U-1918 | 2016-12-01 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N206488-002 | 9506058 | 2034-03-14 | U-1919 | 2016-12-01 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N206488-001 | RE48468 | 2028-10-27 | U-2097 | 2021-04-12 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N206488-001 | RE47769 | 2029-02-02 | Drug product | 2019-12-18 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N206488-001 | 10337003 | 2034-03-14 | U-1918 | 2019-09-10 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N206488-001 | 10364431 | 2034-03-14 | U-1919 | 2019-08-28 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N206488-001 | 10364431 | 2034-03-14 | U-1918 | 2019-08-28 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N206488-001 | 9506058 | 2034-03-14 | U-1918 | 2016-12-01 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N206488-001 | 9506058 | 2034-03-14 | U-1919 | 2016-12-01 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N206488-002 | RE48468 | 2028-10-27 | U-2097 | 2021-04-12 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N206488-002 | RE47769 | 2029-02-02 | Drug product | 2019-12-18 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N206488-002 | 10337003 | 2034-03-14 | U-1918 | 2019-09-10 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N206488-002 | 10364431 | 2034-03-14 | U-1919 | 2019-08-28 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N206488-002 | 10364431 | 2034-03-14 | U-1918 | 2019-08-28 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N206488-002 | 9506058 | 2034-03-14 | U-1918 | 2016-12-01 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N206488-002 | 9506058 | 2034-03-14 | U-1919 | 2016-12-01 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N206488-001 | RE48468 | 2028-10-27 | U-2097 | 2021-04-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206488-001 | RE47769 | 2029-02-02 | Drug product | 2019-12-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206488-001 | 10337003 | 2034-03-14 | U-1918 | 2019-09-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206488-001 | 10364431 | 2034-03-14 | U-1919 | 2019-08-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206488-001 | 10364431 | 2034-03-14 | U-1918 | 2019-08-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206488-001 | 9506058 | 2034-03-14 | U-1918 | 2016-12-01 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206488-001 | 9506058 | 2034-03-14 | U-1919 | 2016-12-01 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206488-002 | RE48468 | 2028-10-27 | U-2097 | 2021-04-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206488-002 | RE47769 | 2029-02-02 | Drug product | 2019-12-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206488-002 | 10337003 | 2034-03-14 | U-1918 | 2019-09-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206488-002 | 10364431 | 2034-03-14 | U-1919 | 2019-08-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N206488-002 | 10364431 | 2034-03-14 | U-1918 | 2019-08-28 | 84e616aacf4f… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N206488-001 | ODE-122 | 2023-09-19 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N206488-002 | ODE-122 | 2023-09-19 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N206488-001 | ODE-122 | 2023-09-19 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N206488-002 | ODE-122 | 2023-09-19 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N206488-001 | ODE-122 | 2023-09-19 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N206488-002 | ODE-122 | 2023-09-19 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N206488-001 | NCE | 2021-09-19 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N206488-001 | ODE-122 | 2023-09-19 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N206488-002 | NCE | 2021-09-19 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N206488-002 | ODE-122 | 2023-09-19 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N206488-001 | ODE-122 | 2023-09-19 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N206488-002 | ODE-122 | 2023-09-19 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N206488-001 | NCE | 2021-09-19 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N206488-001 | ODE-122 | 2023-09-19 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N206488-002 | NCE | 2021-09-19 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N206488-002 | ODE-122 | 2023-09-19 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N206488-001 | NCE | 2021-09-19 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N206488-001 | ODE-122 | 2023-09-19 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N206488-002 | NCE | 2021-09-19 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N206488-002 | ODE-122 | 2023-09-19 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N206488-001 | NCE | 2021-09-19 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N206488-001 | ODE-122 | 2023-09-19 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N206488-002 | NCE | 2021-09-19 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N206488-002 | ODE-122 | 2023-09-19 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N206488-001 | NCE | 2021-09-19 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N206488-001 | ODE-122 | 2023-09-19 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N206488-002 | NCE | 2021-09-19 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N206488-002 | ODE-122 | 2023-09-19 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N206488-001 | NCE | 2021-09-19 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N206488-001 | ODE-122 | 2023-09-19 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N206488-002 | NCE | 2021-09-19 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N206488-002 | ODE-122 | 2023-09-19 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N206488-001 | NCE | 2021-09-19 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N206488-001 | ODE-122 | 2023-09-19 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N206488-002 | NCE | 2021-09-19 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N206488-002 | ODE-122 | 2023-09-19 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N206488-001 | NCE | 2021-09-19 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N206488-001 | ODE-122 | 2023-09-19 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N206488-002 | NCE | 2021-09-19 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N206488-002 | ODE-122 | 2023-09-19 | b00525d2431f… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Exondys 51 | ETEPLIRSEN | Sarepta Therapeutics, Inc. | 33bff678-7829-479e-9110-b8e33a0bc0aa | 2025-08-13 | Warnings, Adverse reactions | 206488 NDA206488 60923-363 60923-284 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 60923-284 | Exondys 51 | eteplirsen | Sarepta Therapeutics, Inc. | NDA | Current |
| 60923-284 | Exondys 51 | eteplirsen | Sarepta Therapeutics, Inc. | NDA | Current |
| 60923-284 | Exondys 51 | eteplirsen | Sarepta Therapeutics, Inc. | NDA | Current |
| 60923-284 | Exondys 51 | eteplirsen | Sarepta Therapeutics, Inc. | NDA | Current |
| 60923-284 | Exondys 51 | eteplirsen | Sarepta Therapeutics, Inc. | NDA | Current |
| 60923-284 | Exondys 51 | eteplirsen | Sarepta Therapeutics, Inc. | NDA | Current |
| 60923-363 | Exondys 51 | eteplirsen | Sarepta Therapeutics, Inc. | NDA | Current |
| 60923-363 | Exondys 51 | eteplirsen | Sarepta Therapeutics, Inc. | NDA | Current |
| 60923-363 | Exondys 51 | eteplirsen | Sarepta Therapeutics, Inc. | NDA | Current |
| 60923-363 | Exondys 51 | eteplirsen | Sarepta Therapeutics, Inc. | NDA | Current |
| 60923-363 | Exondys 51 | eteplirsen | Sarepta Therapeutics, Inc. | NDA | Current |
| 60923-363 | Exondys 51 | eteplirsen | Sarepta Therapeutics, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 80784 | SUPPL | 2024-12-30 |
| 80782 | SUPPL | 2024-12-30 |
| 69927 | SUPPL | 2022-01-19 |
| 69926 | SUPPL | 2022-01-19 |
| 69925 | SUPPL | 2022-01-19 |
| 69906 | SUPPL | 2022-01-19 |
| 69905 | SUPPL | 2022-01-19 |
| 69904 | SUPPL | 2022-01-19 |
| 63839 | SUPPL | 2020-07-09 |
| 63824 | SUPPL | 2020-07-08 |
| 55942 | SUPPL | 2018-10-15 |
| 55898 | SUPPL | 2018-10-12 |
| 54298 | SUPPL | 2018-05-22 |
| 52544 | SUPPL | 2018-02-09 |
| 52524 | SUPPL | 2018-02-09 |
| 45640 | ORIG | 2016-10-26 |
| 45367 | ORIG | 2016-09-19 |
| 45366 | ORIG | 2016-09-19 |
| 45365 | ORIG | 2016-09-19 |